These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12091617)

  • 1. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.1 Differential diagnosis of chronic graft dysfunction.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():4-8. PubMed ID: 12091617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.4. Chronic graft dysfunction. De novo renal disease after transplantation.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():15-6. PubMed ID: 12091620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.3 Chronic graft dysfunction. Non-alloimmune factors.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():11-5. PubMed ID: 12091619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
    Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P
    Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.2 Chronic graft dysfunction. Immunological factors (alloimmunity).
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():8-11. PubMed ID: 12091618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.2. Cardiovascular risks. Arterial hypertension.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():25-6. PubMed ID: 12091630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patients.
    Grinyo JM; Saval N; Campistol JM;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3750-5. PubMed ID: 21474575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our approach to a renal transplant biopsy.
    John R; Herzenberg AM
    J Clin Pathol; 2010 Jan; 63(1):26-37. PubMed ID: 19850567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():50-5. PubMed ID: 12091650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic renal allograft injury: early detection, accurate diagnosis and management.
    Pascual J; Pérez-Sáez MJ; Mir M; Crespo M
    Transplant Rev (Orlando); 2012 Oct; 26(4):280-90. PubMed ID: 22902496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.5. Chronic graft dysfunction. Late recurrence of primary glomerulonephritides.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():16-8. PubMed ID: 12091621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.6. Chronic graft dysfunction. Late recurrence of other diseases.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():18-9. PubMed ID: 12091622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing long-term outcomes following renal transplantation: a review.
    Shrestha BM; Haylor JL
    JNMA J Nepal Med Assoc; 2007; 46(167):136-42. PubMed ID: 18274571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.